Citations (11)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Beatriz Canibaño, Dirk Deleu, Boulenouar Mesraoua, Gayane Melikyan, Faiza Ibrahim & Yolande Hanssens. (2020) Pregnancy-related issues in women with multiple sclerosis: an evidence-based review with practical recommendations. Journal of Drug Assessment 9:1, pages 20-36.
Read now
Read now
Dirk Deleu, Boulenouar Mesraoua, Hisham El Khider, Beatriz Canibano, Gayane Melikyan, Hassan Al Hail, Noha Mhjob, Anjushri Bhagat, Faiza Ibrahim & Yolande Hanssens. (2017) Optimization and stratification of multiple sclerosis treatment in fast developing economic countries: a perspective from Qatar. Current Medical Research and Opinion 33:3, pages 439-458.
Read now
Read now
Athina Papadopoulou, Ludwig Kappos & Till Sprenger. (2015) Safety of teriflunomide for the management of relapsing-remitting multiple sclerosis. Expert Opinion on Drug Safety 14:5, pages 749-759.
Read now
Read now
Articles from other publishers (8)
Isabella Laura Simone, Carla Tortorella & Alma Ghirelli. (2021) Influence of Pregnancy in Multiple Sclerosis and Impact of Disease-Modifying Therapies. Frontiers in Neurology 12.
Crossref
Crossref
Qian-Wen LI, Wen LEI, Cong CHEN & Wei GUO. (2020) Recent advances of long noncoding RNAs involved in the development of multiple sclerosis. Chinese Journal of Natural Medicines 18:1, pages 36-46.
Crossref
Crossref
Yara Dadalti Fragoso, Tarso Adoni, Joseph B. Bidin Brooks, Alessandro Finkelsztejn, Paulo Diniz da Gama, Anderson K. Grzesiuk, Vanessa Daccach Marques, Monica Fiuza K. Parolin, Henry K. Sato, Daniel Lima Varela & Claudia Cristina F. Vasconcelos. (2018) Practical Evidence-Based Recommendations for Patients with Multiple Sclerosis Who Want to Have Children. Neurology and Therapy 7:2, pages 207-232.
Crossref
Crossref
Caila Vaughn, Aisha Bushra, Channa Kolb & Bianca Weinstock-Guttman. (2018) An Update on the Use of Disease-Modifying Therapy in Pregnant Patients with Multiple Sclerosis. CNS Drugs 32:2, pages 161-178.
Crossref
Crossref
Giancarlo Comi, Maria Pia Amato, Antonio Bertolotto, Diego Centonze, Nicola De Stefano, Cinthia Farina, Paolo Gallo, Angelo Ghezzi, Luigi Maria Grimaldi, Gianluigi Mancardi, Maria Giovanna Marrosu, Enrico Montanari, Francesco Patti, Carlo Pozzilli, Leandro Provinciali, Marco Salvetti, Gioacchino Tedeschi & Maria Trojano. (2016) The heritage of glatiramer acetate and its use in multiple sclerosis. Multiple Sclerosis and Demyelinating Disorders 1:1.
Crossref
Crossref
Michelle Fabian. (2016) Pregnancy in the Setting of Multiple Sclerosis. CONTINUUM: Lifelong Learning in Neurology 22:3, pages 837-850.
Crossref
Crossref
Clara Leroy, Jean-Marc Rigot, Maryse Leroy, Christine Decanter, Kristell Le Mapihan, Anne-Sophie Parent, Anne-Claire Le Guillou, Ibrahim Yakoub-Agha, Sébastien Dharancy, Christian Noel & Marie-Christine Vantyghem. (2015) Immunosuppressive drugs and fertility. Orphanet Journal of Rare Diseases 10:1.
Crossref
Crossref
Rebecca S. Farber & Ilana K. Sand. (2015) Optimizing the initial choice and timing of therapy in relapsing-remitting multiple sclerosis. Therapeutic Advances in Neurological Disorders 8:5, pages 212-232.
Crossref
Crossref